Offshoring of Anti-flu Drug and Device Manufacturing Is Potential National Health Threat
Alan Tonelson
Wednesday, October 28, 2009
Offshoring cripples swine flu response
Share of new TAMIFLU production for U.S. market expected to take place overseas: 80%
Number of U.S. government-approved swine flu vaccine manufacturers: 4
Number of these manufacturers producing the vaccine overseas: 3
Estimated share of anti-swine flu respirators made in China: 50%
Estimated share of surgical masks made overseas: 90%
Transcript, “Lou Dobbs Tonight,” CNN, October 21, 2009, http://transcripts.cnn.com/TRANSCRIPTS/0910/21/ldt.01.html 9dIJsPn4U0
Alan Tonelson is a Research Fellow at the U.S. Business & Industry Educational Foundation and the author of The Race to the Bottom: Why a Worldwide Worker Surplus and Uncontrolled Free Trade are Sinking American Living Standards (Westview Press).